Cerebral venous thrombosis and heparin-induced thrombocytopenia in an 18-year old male with severe ulcerative colitis

World Journal of Gastroenterology

Volumn 14, Issue 28, 2008, Pages 4576-4579

  Thorsteinsson, Gudrun Scheving ^a   Magnusson, Maria ^a   Hallberg, Lena M ^a   Wahlgren, Nils Gunnar ^a   Lindgren, Fredrik ^a   Malmborg, Petter ^a   Casswall, Thomas H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebral venous thrombosis; Fondaparinux; Heparin induced thrombocytopenia; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; D DIMER; FONDAPARINUX; HEPARIN; IMMUNOGLOBULIN G ANTIBODY; OLSALAZINE; PENICILLIN G; PREDNISOLONE; STEROID; WARFARIN;

ADULT; ARTICLE; BRAIN PSEUDOTUMOR; CASE REPORT; CEREBROSPINAL FLUID DRAINAGE; CEREBROSPINAL FLUID PRESSURE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEADACHE; HEMATOCHEZIA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MALE; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PAPILLEDEMA; RELAPSE; THROMBOCYTE TRANSFUSION; TONSILLITIS; ULCERATIVE COLITIS; UPPER RESPIRATORY TRACT INFECTION;

EID: 58049119181     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4576     Document Type: Article

References (26)

1. Sawczenko A, Sandhu BK, Logan RF, Jenkins H, Taylor CJ, Mian S, Lynn R. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001; 357: 1093-1094
2. Sutherland L, Macdonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2006; CD000543-CD000544
3. Sands BE. Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories? Gut 2006; 55: 437-441
4. Ozdil S, Akyuz F, Pinarbasi B, Demir K, Karaca C, Boztas G, Kaymakoglu S, Mungan Z, Besisik F, Cakaloglu Y, Okten A. Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?). Hepatogastroenterology 2004; 51: 768-770
5. Masuhr F, Mehraein S. Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment. Neurocrit Care 2004; 1: 355-361
6. Barnes C, Deveber G. Prothrombotic abnormalities in childhood ischaemic stroke. Thromb Res 2006; 118: 67-74
7. Manco-Johnson MJ. How I treat venous thrombosis in children. Blood 2006; 107: 21-29
8. Risch L, Fischer JE, Herklotz R, Huber AR. Heparin-induced thrombocytopenia in paediatrics: clinical characteristics, therapy and outcomes. Intensive Care Med 2004; 30: 1615-1624
9. Derdeyn CP, Powers WJ. Isolated cortical venous thrombosis and ulcerative colitis. AJNR Am J Neuroradiol 1998; 19: 488-490
10. Hasegawa H, Yokomori H, Tsuji T, Hirose R. Hemorrhagic cerebral sinus thrombosis in a case of controlled ulcerative colitis. Intern Med 2005; 44: 155
11. Musio F, Older SA, Jenkins T, Gregorie EM. Case report: cerebral venous thrombosis as a manifestation of acute ulcerative colitis. Am J Med Sci 1993; 305: 28-35
12. Tsujikawa T, Urabe M, Bamba H, Andoh A, Sasaki M, Koyama S, Fujiyama Y, Bamba T. Haemorrhagic cerebral sinus thrombosis associated with ulcerative colitis: a case report of successful treatment by anticoagulant therapy. J Gastroenterol Hepatol 2000; 15: 688-692
13. Umit H, Asil T, Celik Y, Tezel A, Dokmeci G, Tuncbilek N, Utku U, Soylu AR. Cerebral sinus thrombosis in patients with inflammatory bowel disease: a case report. World J Gastroenterol 2005; 11: 5404-5407
14. Twig G, Zandman-Goddard G, Szyper-Kravitz M, Shoenfeld Y. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Ann N Y Acad Sci 2005; 1051: 166-173
15. Kao A, Dlugos D, Hunter JV, Mamula P, Thorarensen O. Anticoagulation therapy in cerebral sinovenous thrombosis and ulcerative colitis in children. J Child Neurol 2002; 17: 479-482
16. Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M. Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Am J Gastroenterol 2007; 102: 174-186
17. Nakano E, Taylor CJ, Chada L, McGaw J, Powers HJ. Hyperhomocystinemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2003; 37: 586-590
18. Romagnuolo J, Fedorak RN, Dias VC, Bamforth F, Teltscher M. Hyperhomocysteinemia and inflammatory bowel disease: prevalence and predictors in a cross-sectional study. Am J Gastroenterol 2001; 96: 2143-2149
19. Oldenburg B, Fijnheer R, van der Griend R, vanBerge-Henegouwen GP, Koningsberger JC. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 2000; 95: 2825-2830
20. Renowden S. Cerebral venous sinus thrombosis. Eur Radiol 2004; 14: 215-226
21. Risch L, Huber AR, Schmugge M. Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res 2006; 118: 123-135
22. Poncz M, Rauova L, Cines DB. The role of surface PF4: glycosaminoglycan complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT). Pathophysiol Haemost Thromb 2006; 35: 46-49
23. Kuo KH, Kovacs MJ. Fondaparinux: a potential new therapy for HIT. Hematology 2005; 10: 271-275
24. Savi P, Chong BH, Greinacher A, Gruel Y, Kelton JG, Warkentin TE, Eichler P, Meuleman D, Petitou M, Herault JP, Cariou R, Herbert JM. Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin. Blood 2005; 105: 139-144
25. Havrda DE, Rathbun S, Scheid D. A case report of warfarin resistance due to azathioprine and review of the literature. Pharmacotherapy 2001; 21: 355-357
26. Begelman SM, Hursting MJ, Aghababian RV, McCollum D. Heparin-induced thrombocytopenia from venous thromboembolism treatment. J Intern Med 2005; 258: 563-572